Greater than expected loss for Akcea Therapeutics By: MarketMinute.com Stock News February 27, 2018 at 17:03 PM EST Akcea Therapeutics Inc. (Nasdaq: AKCA) reported a greater than expected loss for the fourth quarter sending the stock price plunging $5.78 to close at $16.80. Related Stocks: Akcea Therapeutics Inc